Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00740337 · ClinicalTrials.gov registry record
Factors That Affect the Development of COPD Symptoms
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 82
- Enrollment target
NCT00740337: Completed study, sponsored by Washington University School of Medicine.
NCT00740337 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 82 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00740337 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
Chronic obstructive pulmonary disease (COPD) is the fourth most common cause of death in the United States. There is no cure and the disease gets worse over time. Although it usually occurs in people who smoke cigarettes, researchers do not know exactly how smoking leads to COPD. This study will compare blood and tissue samples from smokers and nonsmokers with and without COPD to determine why some COPD symptoms occur in some people and not others.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2007-10 |
| Est. Completion | 2016-02 |
What the finished NCT00740337 record still lists
NCT00740337 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 82 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00740337 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00740337 about?
NCT00740337 is a clinical study titled "Factors That Affect the Development of COPD Symptoms". Chronic obstructive pulmonary disease (COPD) is the fourth most common cause of death in the United States. There is no cure and the disease gets worse over time. Although it usually occurs in people who smoke cigarettes, researchers do not know exactly how smoking leads to COPD. This study will com...
What is the current status of trial NCT00740337?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2007-10. Estimated completion is 2016-02.
Who is sponsoring clinical trial NCT00740337?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia